Oral presentation highlights data showing FLT201 results in durable enzyme expression and sustained clinical benefit in Gaucher disease Preclinical data for SPR301 support best-in-class potential for ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

GOTHENBURG, SE / ACCESS Newswire / May 15, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 15, 2025 - IRLAB Therapeutics AB , a company that discovers and develops new ...

UCSF's psilocybin therapy shows promise for Parkinson's patients 03:40. On a quiet plot of land in rural New Mexico, Jeff Deming feels like he's really living, once again. "Mental ...

Dementia, Alzheimer's and Parkinson's are all brain disorders, and are used interchangeably. Even though not a normal part of ...

It is estimated that 40% of obsessive compulsive disorder (OCD) sufferers do not respond adequately to standard treatments.

An upcoming book details former President Joe Biden's alleged declining health toward the end of his term in office and the ...

An estimated 80,000 people died from overdoses last year, according to provisional Centers for Disease Control and Prevention data released Wednesday, a 27 per cent drop from 2023.

Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...

This transformative model leads to better long-term health outcomes while reducing the need for pharmaceuticals or surgical solutions. AMSA Biotech offers customized treatment plans that utilize ...

A study published in the Journal of Medicinal Chemistry presents a new family of candidate compounds for the treatment of ...

Herantis Pharma has dosed the first patients in the final cohort of its phase 1b clinical trial assessing HER-096, a ...